Angelw Chem: Chinese scholars develop powerful new drugs for pancreatic cancer
-
Last Update: 2020-02-20
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
February 20, 2020 news / Bio Valley bio on / -- pancreatic cancer is one of the most aggressive and fatal malignant tumors in human beings, with a very poor prognosis Therefore, more effective treatment methods are urgently needed to treat pancreatic cancer In order to develop effective new drugs for pancreatic cancer, Wang, from the University of Arizona, USA, recently Wei group proposed a new and effective treatment strategy, that is, using small molecule inhibitors to target both bromine domain and extra terminal domain protein (BET protein) and histone deacetylase (HDAC), researchers designed a series of small molecule drugs reasonably, and screened the most promising drugs for pancreatic cancer treatment Image source: angelw researchers found that a powerful double inhibitor (13a) had good balance activity for brd4bd1 (IC50 = 11nm) and HDAC1 (IC50 = 21nm) It is worth noting that the antitumor activity of the compound in vitro and in vivo is higher than that of bet inhibitor (+) - jq1, HDAC inhibitor vorinostat and their combination, which indicates that this new bet / HDAC double inhibitor has advantages in the treatment of pancreatic cancer, so it is expected to help in the treatment of pancreatic cancer in the future Reference: Wei Wang et al Highly potent dual bet / HDAC inhibitors for the efficient treatment of pancreatic cancer Angel chem 2020 Doi: https://doi.org/10.1002/anie.201915896
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
